Mirowski M - Search Results

1

Synthesis of novel morphiceptin analogues modified in position 3 and their binding to mu-opioid receptors in experimental mammary adenocarcinoma.

Janecka A, Fichna J, Wiercioch R, Mirowski M. Janecka A, et al. Among authors: mirowski m. Bioorg Med Chem. 2003 Sep 1;11(18):3855-60. doi: 10.1016/s0968-0896(03)00448-6. Bioorg Med Chem. 2003. PMID: 12927845

2

Biological investigation of the platinum(II)-[*I]iodohistamine complexes of potential synergistic anti-cancer activity.

Garnuszek P, Liciańska I, Skierski JS, Koronkiewicz M, Mirowski M, Wiercioch R, Mazurek AP. Garnuszek P, et al. Among authors: mirowski m. Nucl Med Biol. 2002 Feb;29(2):169-75. doi: 10.1016/s0969-8051(01)00294-3. Nucl Med Biol. 2002. PMID: 11823121

3

Structure-activity relationship, conformation and pharmacology studies of morphiceptin analogues--selective mu-opioid receptor ligands.

Janecka A, Fichna J, Mirowski M, Janecki T. Janecka A, et al. Among authors: mirowski m. Mini Rev Med Chem. 2002 Dec;2(6):565-72. doi: 10.2174/1389557023405567. Mini Rev Med Chem. 2002. PMID: 12370041 Review.

4

Uptake of radiolabelled alpha-fetoprotein by experimental mammary adenocarcinoma and adenoma: in vivo and in vitro studies.

Mirowski M, S'Witalska J, Wiercioch R, Byszewska E, Niewiadomska H, Michalska M. Mirowski M, et al. Nucl Med Commun. 2003 Mar;24(3):297-303. doi: 10.1097/00006231-200303000-00010. Nucl Med Commun. 2003. PMID: 12612471

5

Uptake of radiolabelled herceptin by experimental mammary adenocarcinoma.

Wiercioch R, Balcerczak E, Byszewska E, Mirowski M. Wiercioch R, et al. Among authors: mirowski m. Nucl Med Rev Cent East Eur. 2003;6(2):99-103. Nucl Med Rev Cent East Eur. 2003. PMID: 14737722

6

Uptake of radiolabeled morphiceptin and its analogs by experimental mammary adenocarcinoma: in vitro and in vivo studies.

Mirowski M, Wiercioch R, Janecka A, Balcerczak E, Byszewska E, Birnbaum G, Byzia S, Garnuszek P, Wierzbicki R. Mirowski M, et al. Nucl Med Biol. 2004 May;31(4):451-7. doi: 10.1016/j.nucmedbio.2003.12.004. Nucl Med Biol. 2004. PMID: 15093815

7

Binding of the new morphiceptin analogs to human MCF-7 breast cancer cells and their effect on growth.

Janecka A, Fichna J, Kosson P, Zalewska-Kaszubska J, Krajewska U, Mirowski M, Rozalski M. Janecka A, et al. Among authors: mirowski m. Regul Pept. 2004 Aug 15;120(1-3):237-41. doi: 10.1016/j.regpep.2004.03.014. Regul Pept. 2004. PMID: 15177942

8

Characterization of the [125I]endomorphin-2 binding sites in the MCF7 breast cancer cell line.

Fichna J, Krajewska U, Rozalski M, Mirowski M, Janecka A. Fichna J, et al. Among authors: mirowski m. Peptides. 2005 Feb;26(2):295-9. doi: 10.1016/j.peptides.2004.09.008. Peptides. 2005. PMID: 15629541

9

Binding of endomorphin-2 to mu-opioid receptors in experimental mouse mammary adenocarcinoma.

Fichna J, do-Rego JC, Mirowski M, Costentin J, Janecka A. Fichna J, et al. Among authors: mirowski m. J Pept Res. 2005 Apr;65(4):459-64. doi: 10.1111/j.1399-3011.2005.00236.x. J Pept Res. 2005. PMID: 15813894

10

Uptake of radiolabelled endomorphins by experimental mammary adenocarcinoma.

Wiercioch R, Mirowski M, Balcerczak E, Byszewska E, Wierzbicki R. Wiercioch R, et al. Among authors: mirowski m. Nucl Med Rev Cent East Eur. 2005;8(1):1-5. Nucl Med Rev Cent East Eur. 2005. PMID: 15977139

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

196 results

Search Page

Filters